Answers are grounded in this paper and cite their sources.
Many patients with end-stage renal disease who are undergoing haemodialysis also have cardiovascular disease. In this article, Ian Hargreaves and David Mantle review the potential role of vitamin K2 supplementation in reducing arterial calcification, and therefore cardiovascular mortality, in haemodialysis patients
No takes yet. Share an insight, caveat, or question.
Hargreaves et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: